StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
TG Therapeutics (TGTX) PT Raised to $30 at JPMorgan
August 7, 2024 6:17 AM
JPMorgan analyst Eric Joseph raised the price target on TG Therapeutics (NASDAQ: TGTX) to $30.00 (from $26.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
HealthCare Royalty and Blue Owl Announce $250M Debt Financing with TG Therapeutics
August 6, 2024 9:01 AM
TG Therapeutics (TGTX) Tops Q2 EPS by 9c
August 6, 2024 7:43 AM
Form 8-K TG THERAPEUTICS, INC. For: Aug 02
August 6, 2024 7:09 AM
TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance
August 6, 2024 7:00 AM
TG Therapeutics to Host Conference Call on Second Quarter 2024 Financial Results and Business Update
August 5, 2024 7:30 AM